PT Murni Sadar Tbk

Jakarta Stock Exchange MTMH.JK

PT Murni Sadar Tbk EBITDA Margin for the year ending December 31, 2023: 8.69%

PT Murni Sadar Tbk EBITDA Margin is 8.69% for the year ending December 31, 2023, a -68.54% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

PT Murni Sadar Tbk EBITDA Margin for the year ending December 31, 2022 was 27.62%, a -9.77% change year over year.
PT Murni Sadar Tbk EBITDA Margin for the year ending December 31, 2021 was 30.61%, a 52.31% change year over year.
PT Murni Sadar Tbk EBITDA Margin for the year ending December 31, 2020 was 20.10%, a 639.36% change year over year.
PT Murni Sadar Tbk EBITDA Margin for the year ending December 31, 2019 was -3.73%, a -155.21% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Jakarta Stock Exchange: MTMH.JK

PT Murni Sadar Tbk

CEO	Dr. - Mutiara M.H.A.
IPO Date	April 20, 2022
Location	Indonesia
Headquarters	Jalan Jawa No. 2, LK II
Employees	3,015
Sector	Health Care
Industries Hospitals & Clinics Telehealth

Description

PT Murni Sadar Tbk, together with its subsidiaries, provides human healthcare services. It operates the Murni Teguh Memorial Hospital located in Medan; the Murni Teguh Tuban Bali Hospital located in Bali; the Murni Teguh Sudirman Jakarta Hospital located in Jakarta; the General hospital Medikarya Aminah Utama located in Tangerang; and the Rumah Sakit Ibu dan Anak Rosiva located in Medan with a total bed capacity of 858 units. The company is headquartered in Medan, Indonesia.

Key trends

Past 5 years